BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1730606)

  • 1. (A-C-B) human proinsulin, a novel insulin agonist and intermediate in the synthesis of biosynthetic human insulin.
    Heath WF; Belagaje RM; Brooke GS; Chance RE; Hoffmann JA; Long HB; Reams SG; Roundtree C; Shaw WN; Slieker LJ
    J Biol Chem; 1992 Jan; 267(1):419-25. PubMed ID: 1730606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production in Escherichia coli of a rat chimeric proinsulin polypeptide carrying human A and B chains and its preparative chromatography.
    Olmos J; Cruz N; Sánchez M; López M; Balbás P; Gosset G; Valle F; Bolivar F
    J Biotechnol; 1994 Nov; 38(1):89-96. PubMed ID: 7765581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification and characterization of recombinant human proinsulin.
    Cowley DJ; Mackin RB
    FEBS Lett; 1997 Feb; 402(2-3):124-30. PubMed ID: 9037180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-A chain disulfide bond (A6-11) of insulin is essential for displaying its activity.
    Dai Y; Tang JG
    Biochem Mol Biol Int; 1994 Aug; 33(6):1049-53. PubMed ID: 7804129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human insulin production from a novel mini-proinsulin which has high receptor-binding activity.
    Chang SG; Kim DY; Choi KD; Shin JM; Shin HC
    Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):631-5. PubMed ID: 9445392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of A7-B7 disulfide bond deletion on the refolding and structure of proinsulin.
    Liu Y; Tang JG
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):122-6. PubMed ID: 12545217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro refolding of human proinsulin. Kinetic intermediates, putative disulfide-forming pathway folding initiation site, and potential role of C-peptide in folding process.
    Qiao ZS; Min CY; Hua QX; Weiss MA; Feng YM
    J Biol Chem; 2003 May; 278(20):17800-9. PubMed ID: 12624089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli.
    Chan SJ; Weiss J; Konrad M; White T; Bahl C; Yu SD; Marks D; Steiner DF
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5401-5. PubMed ID: 7029534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Tyr-C-peptide from genetically altered human insulin precursor.
    Sun H; Tang J; Hu M
    Appl Biochem Biotechnol; 1995 Dec; 55(3):167-74. PubMed ID: 8579343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human insulin. VIII. Isolation of fusion protein--S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells.
    Tikhonov RV; Pechenov SE; Belacheu IA; Yakimov SA; Klyushnichenko VE; Boldireva EF; Korobko VG; Tunes H; Thiemann JE; Vilela L; Wulfson AN
    Protein Expr Purif; 2001 Feb; 21(1):176-82. PubMed ID: 11162404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biosynthesis and isolation of a recombinant protein for producing genetically-engineered human proinsulin].
    Ivankin AN; Mitaleva SI; Nekliudov AD
    Prikl Biokhim Mikrobiol; 1998; 34(3):293-9. PubMed ID: 9644711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
    Robbins DC; Shoelson SE; Rubenstein AH; Tager HS
    J Clin Invest; 1984 Mar; 73(3):714-9. PubMed ID: 6368587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on genetic engineering of human insulin-purification and characterization of human proinsulin and insulin].
    Guo LH; Zhou MY; Shen MH; Wang EB; Liu JF; Yu YJ
    Shi Yan Sheng Wu Xue Bao; 1992 Jun; 25(2):157-63. PubMed ID: 1414126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression in Escherichia coli of a chemically synthesized gene for a "mini-C" analog of human proinsulin.
    Wetzel R; Kleid DG; Crea R; Heyneker HL; Yansura DG; Hirose T; Kraszewski A; Riggs AD; Itakura K; Goeddel DV
    Gene; 1981 Dec; 16(1-3):63-71. PubMed ID: 7044895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidic residues on the N-terminus of proinsulin C-Peptide are important for the folding of insulin precursor.
    Chen LM; Yang XW; Tang JG
    J Biochem; 2002 Jun; 131(6):855-9. PubMed ID: 12038982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-C-peptide human proinsulin.
    Wei G; Hu MH; Tang JG
    Biochem Mol Biol Int; 1995 Jan; 35(1):37-46. PubMed ID: 7735138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of human insulin gene. VIII. Construction of expression vectors for fused proinsulin production in Escherichia coli.
    Guo LH; Stepień PP; Tso JY; Brousseau R; Narang S; Thomas DY; Wu R
    Gene; 1984; 29(1-2):251-4. PubMed ID: 6092228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated Thioredoxin Peptides Serves as an Efficient Fusion Tag for Production of Proinsulin.
    Nataraj NB; Sukumaran SK; Sambasivam G; Sudhakaran R
    Protein Pept Lett; 2020; 27(5):419-431. PubMed ID: 31746289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing.
    Rhodes CJ; Lincoln B; Shoelson SE
    J Biol Chem; 1992 Nov; 267(32):22719-27. PubMed ID: 1429623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and clinical implications of proinsulin conversion intermediates.
    Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
    J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.